To investigate in human adipose tissue a possible relationship between per oxisome proliferator-activated receptor gamma (PPARg) and retinoic acid receptor alpha (RARa) gene expression, two genes involved in the control of adipocyte differentiation. SUBJECTS: Ten lean control women (age 31 -60 y, body mass index (BMI) 18 -24.7 kg=m 2 ) and an obese group of 15 women (age 27 -62 y, BMI 30 -57.5 kg=m 2 ), of whom 10 subjects were in weight-gain phase and five were in weight-loss phase.
Introduction
In humans, adipose tissue is dynamic with the lifelong potential for hyperplasia through preadipocyte replication and differentiation, leading to the development of obesity. This process requires the continuous differentiation of new adipocytes 1 and involves a complex regulatory pathway controlled by the sequential and coordinate expression of specific regulatory genes and several transcription factors. 2, 3 Among these factors, peroxisome proliferator-activated receptor gamma (PPARg), a nuclear receptor which is highly expressed in adipose tissue, is known to be a dominant activator of fat cell differentiation. Furthermore, its expression is induced very early in the adipocyte differentiation. 4 Activated PPARg forms a heterodimer with retinoid X receptors (RXRs) and binds to PPAR response elements occurring in the promoter region of adipose specific genes involved in adipose differentiation, lipid storage and metabolism. 4 White adipose tissue (WAT) plays a key role in the storage and metabolism of lipids and is known as a potential target organ for retinoic acid (RA) action. Indeed, recent studies have indicated that adipose tissue may play an important action in retinoid uptake, storage, mobilization and transport. 5 Moreover, RA receptors, RAR and RXR, which are known to mediate the RA action, are expressed in adipose tissue. 6 It has been established that activation of RA receptors, and in particular the RARa isoform, is required for the inhibition of adipocyte differentiation. 7, 8 Furthermore, recent reports have suggested that convergence of the RA and PPAR signaling pathways regulates the fate of the cultured preadipocytes in acquisition of the adipocyte phenotype. 8, 9 Given the key role that RAR and PPAR play as master regulator genes for differentiation and pro-or antiproliferation in many tissues, increased understanding of these critical factors and how they are regulated will provide insights into adipose tissue development. To illustrate this purpose, it is suggested that modulation of adipose tissue cellularity by food intake involves a potential dysregulation of the genetic development program. We obtained evidence in a previous study in which we examined the effect of exposure to an obesity-inducing diet on the pattern of expression of the RAR, RXR, TR (triiodothyronine receptor) and PPAR nuclear receptors in rat WAT. Thus, data obtained for WAT of rats fed on a fat-rich high-energy diet showed that a significantly decreased expression of RARa and TR was concomitant with an increased expression of PPARg. 10 Since few human studies have been performed, the present work was undertaken to obtain an insight into possible modulation of the expression of these different nuclear receptors in adipose tissue of obese subjects.
Methods

Subjects and tissues
This study included 25 unrelated white female subjects. We studied 10 lean women (mean age 41.8 AE 3.4 y, body mass index (BMI) 23.3 AE 2.8 kg=m 2 ) and a group of 15 obese women (mean age 47.6 AE 2.3 y, BMI 40.9 AE 1.9 kg=m 2 ). The obese group was composed of 10 subjects in the weight-gain phase (defined as weight gain ! 4% or more in body weight over the previous 6 months) and five subjects in the weightloss phase (defined as weight loss ! 4% or more in body weight over the previous 6 months). These latter subjects received nutritional advice in a medical context and were regularly followed. Dietary intake was assessed by food frequency. Among the 10 weight-gain obese patients, six were impaired fasting glucose tolerant (IFGT). None of them received insulin, thiazolidinedione or other hypoglycemic drugs. Moreover, no subject in the entire study was on medications known to affect adipose tissue mass or lipoprotein metabolism. All participants gave their written consent after being informed of the nature of the study. The experimental protocol was approved by the Ethics Committee of the Bordeaux University Hospital and performed according to French legislation (Huriet law).
After an overnight fast, blood was drawn and fasting serum insulin, glucose, triglycerides, cholesterol were measured in blood samples.
Abdominal subcutaneous adipose biopsies were taken under local anesthesia by needle liposuction. The tissue was washed in cold saline and frozen in liquid nitrogen and stored at 7 80 C until analysis.
Total RNA preparation About 60 mg (wet weight) of frozen tissue samples were directly homogenized in 1 ml TRIzol reagent (Invitrogen, France) and total RNA was extracted following the manufacturer's suggested protocol for small quantities of tissue. Purified RNA was quantitated and assessed for purity by UV spectrophotometry. Average yield of total RNA was 7.2 AE 0.7 mg=100 mg of adipose tissue and was not significantly different in tissue from control and obese subjects.
Reverse transcription cDNA was synthesized with Superscript II reverse transcriptase (Invitrogen, France) according to the protocol recommended by the manufacturer with minor modifications. Briefly, 1 mg of total RNA was incubated at 70 C for 5 min and then placed on ice before addition of RT reaction reagents with a specific reverse primer (120 ng) in a final volume of 20 ml. The RT reaction was performed at 42 C for 60 min. Parallel reactions for each RNA samples were run in the absence of RT to assess the degree of any contaminating genomic DNA.
Analysis of gene expression using real-time PCR PCR was carried out using a LightCycler 2 system (Roche Diagnostics, Mannheim, Germany), which combines the processes of amplification and detection (by fluorescence) of a PCR product, enabling on-line and real-time detection. For detection of target gene amplification products, LightCycler DNA Master SYBR Green I was used as described by the manufacturer. PCR reactions were performed in microcapillary tubes in a final volume of 20 ml containing 1X LC-DNA Master SYBR Green I mix, 4 mM of MgCl 2 , 0.5 mM of each primer and 2 ml of cDNA. The amplification conditions were 95 C for 8 min to activate the polymerase, followed by 45 cycles of denaturation at 95 C for 6 s, annealing at 64 C for 6 s, and elongation at 72 C for 10 s. After each elongation phase the fluorescence of SYBR Green I (a double-stranded DNA binding dye) was measured and increasing amounts of PCR products can be monitored from cycle to cycle. The forward and reverse primer sequences are shown in Table 1 . For each primer pair used, melting curve analysis showed a single melting peak after amplification, indicating specific product.
Quantification data were analyzed using the LightCycler analysis software version 3.5 (Roche Diagnostics, Mannheim, Germany). In this analysis, the background fluorescence is removed by setting a noise band. The log -linear portion of the standard amplification curve is identified and the crossing point (Cp) is the intersection of the best-fit line through the log -linear region and the noise band. The standard PPARg and RARa expression in human adipose tissue A Redonnet et al curve is a plot of the Cp vs the amount of initial cDNA used for amplification. Standard curves were generated from 4-fold serial dilutions of target and housekeeping (b-actin) cDNA preparation ( Figure 1) . The relationship between the Cp and the initial amount of cDNA was found to be linear. The correlation coefficient (r) was 1 and PCR amplification efficiencies of the target and the housekeeping gene were similar and close to 100%. These standard curves are used to estimate the concentration of both the target and the b-actin gene in each sample. Then, the results were normalized by the ratio of the relative concentration of target to that of bactin in the same sample.
Statistical analysis
All results are presented as mean AE s.e.m. Statistical significance was assessed using student's t-test and correlation using Pearson's coefficient. The level of significance was set at P < 0.05.
Results
We analyzed dietary intake of weight gain (8456 AE 1150 kJ=day or 2021 AE 275 kcal=day) and weight-loss obese patients (6753 AE 1255 kJ=day or 1614 AE 300 kcal=day). Energy intake from diet was not statistically different between the two obese subgroups as compared to lean patients (7514 AE 255 kJ=day or 1796 AE 255 kcal=day). However, the declared energy intake ranged from 2326 to 24932 kJ=day (556 -5959 kcal=day) in obese patients. Fat dietary energy did not differ between obese in weight-gain phase (40.8%), obese in weight-loss phase (39.1%) and lean patients (40.7%).
The relevant clinical and metabolic characteristics of the patients are shown in Table 2 . Fasting plasma insulin and triglycerides were higher in obese than lean control subjects. In obese subjects, the calculated insulin resistance index (HOMA) 15 values of IFGT subjects ranged from 4 to 6.67, and ranged from 1.62 to 4.89 in non-IFGT subjects (P < 0.05). There was a significant increase of plasma triglycerides in The relative adipose abundance of PPARg mRNA was significantly increase ( þ 91%, P < 0.01) in obese women compared to lean women. To determine the effect of obesity status on expression of PPARg, RARa and TRb in subcutaneous abdominal adipose tissue, we examined separately the level of nuclear receptors mRNA in each subgroup of obese subjects. Figure 2 shows that PPARg level was 125% higher in the weight-gain subjects (P < 0.01) and only 30% higher in the weight-loss subjects relative to the lean controls. Thus the weight-loss obese patients had a 42% lower PPARg level compared with the weight-gain obese group (P < 0.05). We obtained a positive correlation (r ¼ 0.51, P < 0.01) between PPARg mRNA level and the BMI in all subjects (Figure 3) . However, this positive correlation was due to the control group. No correlation between the level of PPARg mRNA in subcutaneous abdominal adipose tissue and BMI was found in weight-gain or weight-loss obese patients. It is important to note that data obtained in IFTG obese patients were not different from those obtained in non-IFTG obese patients.
Associated with body weight changes, a continuous decrease of plasma triglyceride concentrations both in weight-gain and weight -loss subjects and control subjects was observed (1.9 AE 0.3, 1.4 AE 0.2 and 0.9 AE 0.1 g=l, respectively). However, this reduction is significant only between weight-gain obese and control subjects (P < 0.05). In addition, we found a positive correlation between PPARg mRNA level and plasma triglycerides in all subjects (r ¼ 0.45, P < 0.05).
We also examined the RARa mRNA level in relation to the obesity status of subjects. Due to low and variable yield in total RNA recovery in human adipose tissue, we could not measure the mRNA level of RARa in all obese and control subjects. Relative mRNA abundance level of RARa in subcutaneous abdominal adipose tissue of obese subjects is significantly lower than in control subjects ( 7 56%, PPARg and RARa expression in human adipose tissue A Redonnet et al P < 0.01). Again, no IFGT-associated differences were found in the patients. In details in Figure 2 , in weight-gain obese our results showed a clear decrease ( 7 60%, P < 0.01) of RARa mRNA abundance level. Compared with weight-gain obese and control patients, weight-losing obese subjects exhibited an intermediate value of RARa mRNA, but it did not reach significance. However, given the low number of RARa quantification in weight-loss obese group (n ¼ 3), these results have to be considered as partial data. We extended our study to triiodothyronine nuclear receptor (TR) expression because it has been shown that obese animals presented a tissue triiodothyronine resistance. 16 
Figure 3
Relationship between PPARg mRNA level and BMI of the study population. Lean control (squares), n ¼ 10; weight-loss obese (triangles), n ¼ 10, weight-gain obese (circle), n ¼ 5. Figure 4 Relationship between PPARg and RARa mRNA levels in adipose tissue of the study population. Lean control (squares), n ¼ 7, and obese subjects (triangles and circles), n ¼ 12.
PPARg and RARa expression in human adipose tissue
A Redonnet et al Moreover, various links between TR, RAR and PPAR signaling pathways were described. 17, 18 Similar results were obtained with the mRNA level of TRb in adipose tissue of the obese (n ¼ 15) and lean control (n ¼ 10) subjects. However, the decreased expression of TRb in all obese subjects was less marked ( 7 39%, P < 0.05) compared with control subjects than decreased expression of RARa in the same individuals. No difference was observed between the two subgroups of obese ( Figure 2) .
As shown in Figure 4 , a significant negative correlation was found between the mRNA levels of PPARg and RARa in adipose tissue of the subjects (r ¼ 7 0.75, P < 0.01). On the other hand, no correlation between mRNA levels of TRb and PPARg was found in adipose tissue of the subjects ( Figure 5 ).
Discussion
It is important to human obesity that the regulatory system for the differentiation of adipocytes is well defined. It is established that PPARg is a key transcription factor that trigger the entire of adipogenesis. 3, 19 Its role in the control of body weight in animal models has been seen previously, 4 and more recently suggested in humans. 20 Thus it is crucial to identify the factors that are able to modulate PPARg mRNA expression at early stage of adipogenesis, and to determine their regulation in relation to obesity.
Previous studies with conflicting findings concerning the association of PPARg with obesity have been reported. It has been shown that only PPARg 2 was increased and correlated with BMI in subcutaneous adipose tissue of obese subjects, 21 whereas other authors reported no alterations in PPARg 1 or g 2 expression in adipose tissue of obese subjects compared to lean subjects. 22 Our results show that increased PPARg mRNA level in subcutaneous adipose tissue is associated with obesity. Furthermore, it seems to be nutritionally regulated in obese subjects as we have different results in obese patients losing or gaining weight. In our study, PPARg mRNA expression was not correlated to BMI and triglycerides in all obese subjects. In addition, we did not observe any correlation between fasting plasma insulinemia and PPARg mRNA level, although we measured a wide range of fasting plasma insulin concentrations in obese subjects (7 -28 mU=ml) . Taken together, these observations argue for a relationship between PPARg mRNA level in subcutaneous adipose tissue and obesity state independent of the degree of obesity or the blood glucose regulation.
Nevertheless, this finding must be taken with caution because we only determined the abundance of total PPARg mRNA without assessing the specific expression of gamma 1 and 2 isoforms of PPAR in adipose tissue. Moreover, differences in methodology for mRNA quantification added to a heterogeneous, but representative, population of obese used in the present study could explain the discrepancies in results between the previous published studies and our own.
In obese patients, we reported for the first time a decreased expression of RARa mRNA in adipose tissue compared with lean patients. Twenty years ago, RA was first identified as a potent inhibitor of adipocyte differentiation. 23 After this it was shown that differentiation of preadipocyte lines was prevented at an early stage by RA. 24, 25 To date, the mechanism for this effect of RA remains unclear, but this effect seems to be mediated by RARa. 7 The negative correlation between RARa and PPARg mRNA level found in obese and nonobese subjects added to the Figure 5 Relationship between PPARg and TRb mRNA levels in adipose tissue of the study population. Lean control (squares), n ¼ 10, and obese subjects (triangles and circles), n ¼ 15.
PPARg and RARa expression in human adipose tissue A Redonnet et al same negative association found between the weight-gain and the weight-loss subjects suggest that an adaptive response of the regulation of these two nuclear receptors is related to the obesity state. This observation is consistent with results suggesting that a threshold level of RAR is required for retinoic acid inhibition of adipogenesis. 8 In the current study, no relation was found between TR and PPARg or RAR mRNA level in adipose tissue, despite a lower expression of TR mRNA in obese subjects. This result argue in favor of a preferential and dynamic cross-talk between PPARg and retinoid signaling pathways associated with the regulation of adipose tissue plasticity.
Obesity is often associated with a disturbance in energy balance in part due to an excessive food intake. In this study, we did not observe a significant difference in declared food intake between the three groups because the range of obese energy intake was too large. However, previous work in rodents has reported that PPARg is regulated in vivo by diet rich in fatty acids. 26 Similarly, in a previous study, we observed an up-regulation of PPARg mRNA level in WAT of high-fat fed animals with a concomitant decreased level of RARa and TR mRNA level, whereas RXRa mRNA level was unchanged. 10 These data suggest that nutrition can affect the retinoid and PPAR signaling pathways in WAT. Significance as well as mechanisms of these phenomenons remain unknown. However, it is possible that modulation in expression of RAR and PPAR (and maybe TR) occurring in these tissues could be an important event in the early body adaptive mechanisms leading to the hyperplasy and the hypertrophy of adipose tissue.
More generally, excessive food intake (ie rich in lipids) might induce an allostatic state because of disturbances in fatty acids and retinoid nuclear receptor signaling pathways in different target tissues. For instance, RAR modulation will be one event promoting the adipose tissue plasticity in response to a high energy intake, and leading to the development of obesity. On the other hand, such as abnormal expression of the RAR could be related to the occurrence of certain types of cancer. Thus, in a colon carcinogenesisinduced animal model, we observed a decreased expression of RARb mRNA in colon of rats fed a high-fat diet (unpublished observations). This information could be related to the epidemiological data showing that obese patients were at higher risk of colon cancer. 27, 28 In conclusion, disturbances in the pattern of expression of these nuclear receptors could favor the adverse health consequences associated with increasing body weight. A better knowledge of the nuclear receptor signaling pathway interactions will provide new insights into adipose tissue plasticity in the onset of obesity.
